According to the research done by Iida et al., luteolin increases p21 in BUCs, causes G2/M phase arrest, reduces phosphorylated-mTOR and its downstream effector protein p-S6K, and blocks protein synthesis and tumor growth [116]. Here, MTOR is linked to neoplasm.